首页|奥拉帕尼诱导乳腺癌MCF-7细胞衰老作用及其机制

奥拉帕尼诱导乳腺癌MCF-7细胞衰老作用及其机制

扫码查看
目的 研究奥拉帕尼(olaparib)诱导乳腺癌MCF-7 细胞衰老作用的表现及其相关分子水平作用机制.方法 利用实时细胞分析(real-time cell analysis,RTCA)技术实时动态检测抗增殖和抗迁移活性;应用衰老相关β-半乳糖苷酶(senescence-associated β-galactosidase,SA-β-gal)染色法观察诱导细胞衰老活性;通过qPCR分析奥拉帕尼对衰老相关基因p16、p21、C/EBP同源蛋白(C/EBP homologous protein,CHOP)、白细胞介素(interleukin,IL)-6、IL-8、纤溶酶原激活物抑制剂-1(plasminogen activator inhibitor 1,PAI-1)、磷酸酶和张力蛋白同源物(phosphatase and tensin homolog deleted on chromosome 10,PTEN)、p27、视网膜母细胞瘤基因(retinoblastoma gene,RB1)、Ki67 和E2F1 表达的影响;根据Western Blot分析奥拉帕尼对衰老相关蛋白 p21、γH2AX、胰岛素样生长因子结合蛋白 3(insulin-like growth factor binding protein 3,IGFBP3)、cyclin D1、pRB和Ki67 表达的影响.结果 奥拉帕尼能够抑制乳腺癌MCF-7 细胞增殖、迁移并诱导 MCF-7 细胞的衰老;奥拉帕尼作用 96h 的 MCF-7 细胞中 p16、p21、p27、CHOP、IL-6、IL-8、PAI-1、PTEN和RB1 的基因表达水平显著上调(P<0.01),Ki67 和E2F1 的基因表达水平显著下调(P<0.01);MCF-7细胞中p21、γH2AX和IGFBP3 蛋白的表达水平显著升高(P<0.01,P<0.01,P<0.05),cyclin D1、pRB和Ki67 蛋白的表达水平显著降低(P<0.05,P<0.01,P<0.05).结论 奥拉帕尼能够通过抗增殖、迁移和诱导细胞衰老产生抗乳腺癌MCF-7细胞作用.
Effect and mechanism of olaparib on senescence of MCF-7 breast cancer cells
Objective To study the cellular senescence and molecular mechanism of olaparib in MCF-7 breast cancer cells.Methods The effects of olaparib on the proliferation and migration of MCF-7 cells were detected dynamically by real-time cell analysis(RTCA)technology.The effects of olaparib on the Senescence was detected by using the senescence-associated β-galactosidase(SA-β-gal).Quantitative polymerase chain reaction was used to analyze the effects of olaparib on the expression levels of genes encoding the senescence-associated factors p16,p21,C/EBP homologous protein,interleukin(IL)-6,IL-8,plasminogen activator inhibitor 1,phosphatase and tensin homolog deleted on chromosome 10,p27,retinoblastoma gene,Ki67,and E2F1.The effects of olaparib on the expression levels of the senescence-associated proteins p21,γH2AX,pRB,cyclin D1,insulin-like growth factor binding protein 3,and Ki67 were analyzed by Western Blot.Results Olaparib inhibited the proliferation and migration and induced the senescence of MCF-7 cells.Long-term(96 h)treatment with olaparib significantly up-regulated the gene expression levels of p16,p21,p27,C/EBP homologous protein,IL-6,IL-8,plasminogen activator inhibitor 1,phosphatase and tensin homolog deleted on chromosome 10,and retinoblastoma protein(P<0.01)and significantly down-regulated the gene expression levels of Ki67 and E2F1(P<0.01)in MCF-7 cells.Olaparib significantly increased protein expression levels of p21,γH2AX,and insulin-like growth factor binding protein 3 in MCF-7 cells(P<0.01,P<0.01,P<0.05)and significantly decreased cyclin D1,pRB,and Ki67 levels(P<0.05,P<0.01,P<0.05).Conclusions Olaparib can inhibit proliferation and migration and induce senescence in MCF-7 breast cancer cells.

olaparibbreast cancersenescence

王大伟、郭晶、边继春、王莎莎、卢美超、张岱州、贾玉萍

展开 >

山东中医药大学,济南 250355

山东省药学科学院,济南 250098

奥拉帕尼 乳腺癌 衰老

济南市"高校20条"资金项目中央引导地方科技发展专项复旦大学分子病毒学重点实验室开放基金

2020GXRC043YDZX2021023FDMV-2021005

2024

中国实验动物学报
中国实验动物学会,中国医学科学院医学实验动物研究所

中国实验动物学报

CSTPCD北大核心
影响因子:0.767
ISSN:1005-4847
年,卷(期):2024.32(3)